These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 28714007)

  • 1. Long non-coding RNA LINK-A promotes glioma cell growth and invasion via lactate dehydrogenase A.
    Wu D; Zhao B; Cao X; Wan J
    Oncol Rep; 2017 Sep; 38(3):1525-1532. PubMed ID: 28714007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ZFAS1 is an unfavourable prognostic factor and promotes glioma cell progression by activation of the Notch signaling pathway.
    Gao K; Ji Z; She K; Yang Q; Shao L
    Biomed Pharmacother; 2017 Mar; 87():555-560. PubMed ID: 28081466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis.
    Liu X; Zhu Q; Guo Y; Xiao Z; Hu L; Xu Q
    Biomed Pharmacother; 2019 Sep; 117():109069. PubMed ID: 31181442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.
    Dong CY; Cui J; Li DH; Li Q; Hong XY
    Oncol Rep; 2018 Nov; 40(5):2573-2583. PubMed ID: 30132568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
    Xu C; He T; Li Z; Liu H; Ding B
    Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of Long Non-Coding RNA (LncRNA) Non-Coding RNA Activated by DNA Damage (NORAD) Inhibits Proliferation, Invasion, Migration, and Promotes Apoptosis of Glioma Cells via Downregulating the Expression of AKR1B1.
    Luo L; Chen C; He H; Cai M; Ling C
    Med Sci Monit; 2020 Jul; 26():e922659. PubMed ID: 32778640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma.
    Wang Q; Li Q; Zhou P; Deng D; Xue L; Shao N; Peng Y; Zhi F
    Biomed Pharmacother; 2017 Jul; 91():906-911. PubMed ID: 28501778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-200b is a key regulator of tumor progression and metabolism targeting lactate dehydrogenase A in human malignant glioma.
    Hu S; Jiang Q; Luo D; Zhao L; Fu X; Chen Y; Song X; Li L; Zhao H; He Y; Peng B
    Oncotarget; 2016 Jul; 7(30):48423-48431. PubMed ID: 27374173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA LINC01857 promotes growth, migration, and invasion of glioma by modulating miR-1281/TRIM65 axis.
    Hu G; Liu N; Wang H; Wang Y; Guo Z
    J Cell Physiol; 2019 Dec; 234(12):22009-22016. PubMed ID: 31049960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA MT1JP inhibits proliferation, invasion, and migration while promoting apoptosis of glioma cells through the activation of PTEN/Akt signaling pathway.
    Zhang Y; Sui R; Chen Y; Liang H; Shi J; Piao H
    J Cell Physiol; 2019 Nov; 234(11):19553-19564. PubMed ID: 31066040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA SNHG12promotes the proliferation and migration of glioma cells by binding to HuR.
    Lei W; Wang ZL; Feng HJ; Lin XD; Li CZ; Fan D
    Int J Oncol; 2018 Sep; 53(3):1374-1384. PubMed ID: 30015836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of long noncoding RNA SPRY4-IT1 suppresses glioma cell proliferation, metastasis and epithelial-mesenchymal transition.
    Liu H; Lv Z; Guo E
    Int J Clin Exp Pathol; 2015; 8(8):9140-6. PubMed ID: 26464658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Artesunate attenuates glioma proliferation, migration and invasion by affecting cellular mechanical properties.
    Lian S; Shi R; Huang X; Hu X; Song B; Bai Y; Yang B; Dong J; Du Z; Zhang Y; Jia J; Ma N; Guo G; Wang M
    Oncol Rep; 2016 Aug; 36(2):984-90. PubMed ID: 27279152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A4 expression is closely linked to genesis and progression of glioma by regulating proliferation, apoptosis, migration and invasion.
    Jin T; Zhang Z; Yang XF; Luo JS
    Asian Pac J Cancer Prev; 2015; 16(7):2883-7. PubMed ID: 25854377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non-coding RNA PAR5 inhibits the proliferation and progression of glioma through interaction with EZH2.
    Wang XP; Shan C; Deng XL; Li LY; Ma W
    Oncol Rep; 2017 Nov; 38(5):3177-3186. PubMed ID: 29048683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells.
    Zhang D; Zhou H; Liu J; Mao J
    Biomed Res Int; 2019; 2019():5437531. PubMed ID: 30949502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA ATB promotes glioma malignancy by negatively regulating miR-200a.
    Ma CC; Xiong Z; Zhu GN; Wang C; Zong G; Wang HL; Bian EB; Zhao B
    J Exp Clin Cancer Res; 2016 Jun; 35(1):90. PubMed ID: 27267902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells.
    Guo H; Hu G; Yang Q; Zhang P; Kuang W; Zhu X; Wu L
    Oncotarget; 2016 Dec; 7(49):81806-81814. PubMed ID: 27833083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.
    Lv QL; Chen SH; Zhang X; Sun B; Hu L; Qu Q; Huang YT; Wang GH; Liu YL; Zhang YY; Zhou HH
    Tumour Biol; 2017 Mar; 39(3):1010428317695022. PubMed ID: 28349823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of long non-coding RNA ENSG00000226738 (LncKLHDC7B) is enriched in the immunomodulatory triple-negative breast cancer subtype and its alteration promotes cell migration, invasion, and resistance to cell death.
    Beltrán-Anaya FO; Romero-Córdoba S; Rebollar-Vega R; Arrieta O; Bautista-Piña V; Dominguez-Reyes C; Villegas-Carlos F; Tenorio-Torres A; Alfaro-Riuz L; Jiménez-Morales S; Cedro-Tanda A; Ríos-Romero M; Reyes-Grajeda JP; Tagliabue E; Iorio MV; Hidalgo-Miranda A
    Mol Oncol; 2019 Apr; 13(4):909-927. PubMed ID: 30648789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.